Metformin, commonly used in type 2 diabetes (T2D) management, exerts neuroprotective effects through AMPK activation, reducing mitochondrial dysfunction, oxidative stress and α-synuclein aggregation [235,236]. This evidence concerns the gene SNCA and type 2 diabetes mellitus.